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SUMMARY 
We share our experience of a 50-year-old controlled 
hypertensive woman who had routine cataract surgery 
in her left eye. She was given retrobulbar Xylocaine 
with adrenalin and postoperative gentamycin .She sub-
sequently became blind in the operated eye after devel-
oping macular infarction by the first day post operative 
and optic atrophy by 2 months postoperative. This 
could have been caused by vascular occlusion in an 
already compromised artherosclerosed vessels. It could 
also have been due to gentamyin toxicity. Gentamycin 
injection given subconjunctivally is known to rarely 
result in severe retinal toxicity. This case illustrates that 
even though cataract surgery is considerd a simple rou-
tine procedure, and is performed in high volumes, it is 
not without its blinding complications. We recommend 
that the use of adrenaline in xylocaine should be used 
with caution in hypertensive patients and also the rou-
tine use of subconjunctival gentamycin injection after 
cataract surgery should be reviewed and other modes 
of endophthalmitis prophylaxis be considered. 
 
INTRODUCTION  
Cataract is a blinding condition resulting from an opac-
ity of the crystalline lens of the eye. It is the most 
common cause of blindness in Ghana and worldwide.  
The only treatment to restore sight is by performing 
cataract surgery to remove the opaque lens. Therefore 
cataract surgery represents the most frequent surgical 
procedure performed by most ophthalmic surgeons. 
The 2010 eye care report indicates that in Ghana, 
18,405 cataract operations were performed.1 
 
Cataract surgery has its complications. The most feared 
complication of the procedure is endophthalmitis as a 
result of intraocular infection. To prevent this serious 
complication many surgeons employ various measures, 
including the use of a subconjunctival injection of a 
bolus of gentamycin immediately post operative2. In 
Ghana many eye centres routinely use subconjunctival 
injection of gentamycin as post operative prophylaxis 
for endophthalmitis. All antibiotics however have the 
potential to cause significant ocular toxicity when they 
gain access into the intraocular tissues. 
The Aminoglycosides, in particular gentamycin, are the 
most toxic of the antibiotics commonly used in oph-
thalmology.3,4 A subconjunctival injection of gentamy-
cin and other aminoglycosides has the potential of 
causing severe complications that can result in loss of 
sight. These complications, though rare, are well doc-
umented in the literature. The clinical presentation of 
gentamycin toxicity resembles a vaso-occlusive and 
non-perfusion event5 and includes macular infarction 
and optic atrophy.6 Extreme caution is needed when 
administering a periocular injection of aminoglycoside 
for treatment or prophylaxis of infection.3  
 
To achieve anaesthesia in adults, retrobulbar or 
peribulbar injection of xylocaine with adrenaline is also 
routinely given. According to Huber and Remky 4, in 
addition to complications like central retinal artery 
occlusion, ischaemic optic neuropathy and retinal or 
outer retinal ischaemia, retrobulbar xylocaine (when 
compared with subconjunctival xylocaine) induces a 
high reduction of velocity of blood flow in the 
retrobulbar vessels. Xylocaine is sometimes used in 
combination with adrenaline (a vasoconstrictor) to 
promote local haemostasis, reduce systemic absorption 
and prolong the duration of action of xylocaine. This 
vasoconstrictive effect of adrenaline has its disad-
vantages and may severely reduce blood flow in pa-
tients with damaged or susceptible blood vessels.  
 
The ocular complications of hypertension are vaso oc-
clusive in nature and are similar to that of subconjuc-
tival xylocaine and adrenaline. They include central 
retinal artery occlusion, optic atrophy and retinal is-
chemia. The use of xylocaine with adrenaline in a pa-
tient with hypertension considerably increases the risks 
of vascular occlusion in an already susceptible and 
compromised eye. 
 
In this case, the combinations of retrobulbar injections 
of xylocaine, adrenaline and postoperative injection of 
gentamycin and hypertension are all associated with 
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The purpose of this case study is to illustrate the poten-
tial of inducing an acute severe ocular vascular occlu-
sion after “routine” cataract surgery in a patient with 




We present the case of a 50 year old woman who is a 
known hypertensive, with blood pressure of 110/80 
mm Hg on oral nifedipine 40 mg daily  who presented 
with 6/36 vision in both eyes and intolerable glare, 
preventing her from driving at night. 
  
Examination revealed posterior subcapsular cataract in 
both eyes. There was normal pupillary reaction to light 
in both eyes and no relative afferent pupillary defect. 
Macular function using the Maddox rod technique was 
normal. Funduscopy showed a normal optic disc, mac-
ula and retinal vessels in both eyes. Intraocular pres-
sures were normal (16mmHg) in both eyes. She was 
scheduled for cataract surgery on her left eye. 
 
She received a retrobulbar injection of 5mls of 2% xy-
locaine with 1 in 100000 adrenaline for anaesthesia. 
There was no retrobulbar haemorrhage. Routine small 
incision cataract surgery (SICS), performed with inser-
tion of +18.0 Dioptre posterior chamber intra-ocular 
lens implant, was uneventful and uncomplicated. She 
received sub-conjunctival injection of gentamycin 
(20mg in 0.5ml) and dexamethasone (1mg in 0.5ml) 
injection immediately after surgery.  
 
On her first postoperative day review, her visual acuity 
in the operated eye was nil perception of light (NPL). 
Vision in her other eye was 6/36. Evaluation of the 
operated eye showed clear cornea, pupils were round 
with mild afferent pupillary defect. The intraocular lens 
(IOL) was central and there was no wound leak. A 
cherry-red spot lesion at the macular was noted, with 
normal looking optic nerve. Fundus photography and 
fluorescein angiography were not performed because 
of unavailability of these facilities at the time that this 
case occurred. The macular lesion did not resolve on 
follow-up. Subsequently by 2 months post operative , 
she also developed a frank optic atrophy. Her vision 
was NPL. One year post operative, vision in her left 
eye remains NPL and her optic nerve is pale. 
 
DISCUSSION 
Macular infarction and extensive retinal non-perfusion, 
though uncommon, may occur after uncomplicated 
subconjunctival injection of Aminoglycosides (espe-
cially Gentamycin) for prophylaxis against endoph-
thalmitis after cataract surgery. The clinical picture 
resembles a central retinal artery occlusion.7 
Post-operative endophthalmitis is the most common 
form of endophthalmitis, making up 70% of all cases 
of infectious endophthalmitis.8 Out of these cases, oc-
currence after cataract surgery is the greatest (80%).9 
Endophthalmitis is also considered as an emergency 
because of its associated profound and irreversible vis-
ual loss. 
 
The Endophthalmitis Vitrectomy study found the main 
infective organisms in post operative endophthalmitis 
to be Gram positive organisms, with Gram negative 
organisms contributing only 6.0%.9 The study also re-
ported that although Gentamycin was used initially for 
the treatment of endophthalmitis, it was found to be 
associated with retinal toxicity. 
 
In view of the high incidence of endophthalmitis after 
cataract surgery and its disabling nature in terms of 
profound vision loss, it is important to consider 
prophylaxis against the infection. The drug of choice is 
Amikacin in combination with Vancomycin, which has 
a broad spectrum of action against Gram positive and 
especially Gram negative organisms.10 Gentamycin, 
which belongs to the same drug class as amikacin (both 
are Aminoglycosides) is used in certain centers, espe-
cially the resource-poor ones. 
 
However there are increasing reports of gentamycin-
induced macular toxicity. A survey by Campochiaro et 
al reported 23 cases of macular infarction in eyes that 
were treated with prophylactic subconjunctival injec-
tions of aminoglycosides after routine ocular surgery. 
The recommendation was that the role of aminoglyco-
sides in the prophylaxis of ocular infections and the 
management of endophthalmitis should be re-
evaluated.11 
 
Cardascia et al12.concluded in their case report on gen-
tamycin-induced macular infarction in transconjuncti-
val sutureless 25-gauge vitrectomy that antibiotics, in 
particular gentamycin, have the potential to cause sig-
nificant ocular toxicity when they gain access to the 
inside of the eye, through thinned sclera or sutureless 
sclerotomies of transconjunctival sutureless vitrectomy. 
  
The potential for causing macular infarction has led the 
American Academy of Ophthalmology to recommend 
in its Basic and Clinical Science course that “routine 
subconjunctival aminoglycoside prophylaxis at the 
conclusion of cataract surgery is no longer recom-
mended”.7 
 
The cherry red spot and subsequent optic atrophy 
found in this patient are suggestive of a generalised 
vaso-occlusive neurotoxic event of the retina.  
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Even though causality cannot be proven in this case, 
we believe this could have been caused by several fac-
tors, such as macular infarction induced by subcon-
junctival injection of gentamycin, arterial constriction 
in an already artherosclerosed artery caused by the 
retrobulbar injection of adrenaline or xylocaine, or di-
rect injection of xylocaine into the optic nerve. 
 
Surgical complications, which could have caused a 
vaso-occlusive event, were absent: there was no 
retrobulbar haemorrhage and no intraoperative positive 
pressure in this patient. The patient’s blood pressure 
was controlled at the time of the cataract surgery there 
are no known ocular complications for the oral nifedi-
pine that this patient was on or any known significant 
interaction between nifidipine and any of the peri-
operative medications she received. 
 
Intraocular administration of aminoglycosides is asso-
ciated with retinal toxicity. The clinical manifestations 
resemble a vaso-occlusive event which includes oede-
ma, intraretinal haemorrhage, and nonperfusion detect-
ed by fluorescein angiogram.  Electroretinogram (ERG) 
studies show that following intraocular administration 
of gentamycin, a component of the toxicity may be 
mediated through pathways other than vascular supply 
– possibly a receptor mediated process.13 
 
The use of post-operative subconjunctival injection of 
gentamycin together with pre operative retrobulbar 
xylocaine and adrenaline is still widely practiced in 
many centres in Ghana. Their potential dangers are 
probably not recognised, even though there is enough 
evidence in the literature that they can cause damage to 
retinal vessels. In addition, subconjunctival gentamycin 
is probably quite ineffective for the common organisms 
responsible for endophthalmitis. 
 
As far as we know of, no study has been done to look 
at the incidence of post operative endophthalmitis and 
the effectiveness or not of subconjuctival injection of 
gentamycin in this country. 
 
CONCLUSIONS  
This case reminds us that even routine and uncompli-
cated cataract surgeries can be associated with severe 
unfavourable outcomes. More studies are needed to 
identify these complications and the associated risks, 
so as to improve the outcome of cataract surgeries. 
There is a need to revisit the routine use of postopera-
tive prophylactic subconjunctival injection of gentamy-
cin in Ghana.  
 
The instillation of pre-operative povidone iodine 5% in 
the conjunctival sac, which has been shown to have the 
same reduction of the incidence of endophthalmitis as 
preoperative and postoperative antibiotics should be 
encouraged. There should be rigorous attention to in-
traoperative aseptic conditions. 
 
The use of intra-cameral cefuroxime has been recom-
mended as a prophylaxis for endophthalmitis. Although 
it has been found to be useful and effective, the prepa-
ration of the correct dosage can be quite challenging. 
The use of this mode of prophylaxis has the potential 
of causing serious damage to the eye, especially if the 
exact concentration and composition are not mixed 
rightly. Intra-cameral cefuroxime has also been recent-
ly shown to cause macular infarction.14,15 
 
Retrobulbar injection of xylocaine with adrenaline 
should be given with caution, especially in patients 
with vaso occlusive disease even if their condition is 
stable and well managed. The risk of ocular vascular 
occlusion after retrobulbar injections in such patients 
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